Terms: = Prostate cancer AND PREX2, 6230420N16Rik, DEPDC2, 80243, ENSG00000046889, FLJ12987, DEP_2, P-REX2
6 results:
1. Genetic mutations in smoking-associated prostate cancer.
Elshafei A; Al-Toubat M; Feibus AH; Koul K; Jazayeri SB; Lelani N; Henry V; Balaji KC
Prostate; 2023 Sep; 83(13):1229-1237. PubMed ID: 37455402
[TBL] [Abstract] [Full Text] [Related]
2. Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model.
Zhao Y; Peng X; Baldwin H; Zhang C; Liu Z; Lu X
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166151. PubMed ID: 33892077
[TBL] [Abstract] [Full Text] [Related]
3. Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric cancer.
Zhou J; Zhao W; Wu J; Lu J; Ding Y; Wu S; Wang H; Ding D; Mo F; Zhou Z; Teng L; Chen S
Biomed Res Int; 2019; 2019():8103142. PubMed ID: 31312661
[TBL] [Abstract] [Full Text] [Related]
4. P-Rex1 and p-rex2 RacGEFs and cancer.
Srijakotre N; Man J; Ooms LM; Lucato CM; Ellisdon AM; Mitchell CA
Biochem Soc Trans; 2017 Aug; 45(4):963-77. PubMed ID: 28710285
[TBL] [Abstract] [Full Text] [Related]
5. EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations.
Lavallée VP; Gendron P; Lemieux S; D'Angelo G; Hébert J; Sauvageau G
Blood; 2015 Jan; 125(1):140-3. PubMed ID: 25331116
[TBL] [Abstract] [Full Text] [Related]
6. Molecular pathways: P-Rex in cancer.
Pandiella A; Montero JC
Clin Cancer Res; 2013 Sep; 19(17):4564-9. PubMed ID: 23753921
[TBL] [Abstract] [Full Text] [Related]
